These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 8243687
1. Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in indonesian men. World Health Organization. Task Force on Methods for the Regulation of Male Fertility. Fertil Steril; 1993 Dec; 60(6):1062-8. PubMed ID: 8243687 [Abstract] [Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869 [Abstract] [Full Text] [Related]
3. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men. Pangkahila W. Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798 [Abstract] [Full Text] [Related]
4. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. Behre HM, Nashan D, Hubert W, Nieschlag E. J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833 [Abstract] [Full Text] [Related]
5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM, Gow SM, Wu FC. J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [Abstract] [Full Text] [Related]
6. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM. J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [Abstract] [Full Text] [Related]
7. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Guerin JF, Rollet J. Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439 [Abstract] [Full Text] [Related]
8. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Knuth UA, Yeung CH, Nieschlag E. Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404 [Abstract] [Full Text] [Related]
9. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. McLachlan RI, O'Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM, Robertson DM. J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283 [Abstract] [Full Text] [Related]
10. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C. Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551 [Abstract] [Full Text] [Related]
11. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS. J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [Abstract] [Full Text] [Related]
12. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E. J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113 [Abstract] [Full Text] [Related]
13. Suppression of spermatogenesis by testosterone enanthate in Thai men. Aribarg A, Sukcharoen N, Chanprasit Y, Ngeamvijawat J, Kriangsinyos R. J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996 [Abstract] [Full Text] [Related]
14. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Soufir JC, Jouannet P, Marson J, Soumah A. Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496 [Abstract] [Full Text] [Related]
15. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM. J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300 [Abstract] [Full Text] [Related]
16. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. Kamischke A, Venherm S, Plöger D, von Eckardstein S, Nieschlag E. J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016 [Abstract] [Full Text] [Related]
19. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Behre HM, Kliesch S, Lemcke B, von Eckardstein S, Nieschlag E. Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576 [Abstract] [Full Text] [Related]
20. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C. J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475 [Abstract] [Full Text] [Related] Page: [Next] [New Search]